Strategy nursing administration of immunosuppressive and immunomodulatory drugs in patients with multiple sclerosis

被引:0
|
作者
Grass Fernandez, Daymet [1 ]
Cabrera Gomez, Jose Antonio [1 ]
Diaz de la Fe, Amado [1 ]
机构
[1] Ctr Int Restaurac Neurol, Havana, Cuba
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
9
引用
收藏
页码:131 / 131
页数:1
相关论文
共 50 条
  • [21] Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis
    Duchi, Shaher
    Ovadia, Haim
    Touitou, Elka
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 258 (1-2) : 32 - 40
  • [22] Effectiveness and tolerability of immunomodulatory drugs in multiple sclerosis during childhood or adolescence
    Ghezzi, A
    Gallo, P
    Marrosu, G
    Milani, N
    Milanese, C
    Pilato, V
    Trojano, M
    Zaffaroni, M
    Comi, G
    NEUROLOGY, 2004, 62 (07) : A487 - A487
  • [23] Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude
    Teixeira, Marcus Zulian
    HOMEOPATHY, 2013, 102 (03) : 215 - 224
  • [24] Current concepts on the use of immunomodulatory drugs in the treatment of multiple sclerosis.
    Correale, J
    Cristiano, E
    MEDICINA-BUENOS AIRES, 2001, 61 (04) : 470 - 480
  • [25] Recent Advances on Immunosuppressive Drugs and Remyelination Enhancers for the Treatment of Multiple Sclerosis
    Cadenas-Fernandez, Jennifer
    Ahumada-Pascual, Pablo
    Andreu, Luis Sanz
    Velasco, Ana
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (30) : 3273 - 3280
  • [26] The use of immunomodulatory therapy in pregnant patients with multiple sclerosis
    Rudnicka-Czerwiec, Julia
    Popiel, Malgorzata
    Bartosik-Psujek, Halina
    AKTUALNOSCI NEUROLOGICZNE, 2018, 18 (03): : 123 - 131
  • [27] Skin lesions in multiple sclerosis patients on immunomodulatory treatment
    Gines, M. Martinez
    Campos, M.
    de la Cueva, P.
    Esquivel, A.
    Barriga, N. Martin
    de Andres, C.
    MULTIPLE SCLEROSIS, 2008, 14 : S164 - S164
  • [28] Vaccines that should be administered to patients receiving treatment with immunosuppressive, immunomodulatory and/or biological drugs
    Peremiquel-Trillas, Paula
    Maria Leguizamo, Lina
    Asensio Ostos, Carmen
    Martinez-Gomez, Xavier
    MEDICINA CLINICA, 2018, 151 (12): : 498 - 502
  • [29] Adherence to immunomodulatory drugs in Brazilian patients with multiple myeloma
    Silveira, Livia Pena
    de Miranda Drummond, Paula Lana
    Malta, Jessica Soares
    Costa, Naiane Lima
    Marques dos Santos, Roberta Marcia
    Lopes Machado, Taisa Roberta
    Moreira Reis, Adriano Max
    Menezes de Padua, Cristiane Aparecida
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 191 - 192
  • [30] Cancer risk of immunosuppressive treatment in multiple sclerosis patients
    Alba-Suarez, E.
    Diaz-Diaz, J.
    Gomez-Estevez, I.
    Luque-Alarcon, M.
    Martinez-Sesmero, J.
    Pena-Pedrosa, J.
    Oreja-Guevara, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 636 - 636